Session Details

Session Details

01:30 PM - 03:15 PM - Room 339-342

M Graça Almeida-Porada - MD, PhD - Wake Forest School of Medicine

Co-Chair

01:30 PM - 03:15 PM - Room 339-342

Satiro De Oliveira - MD - UCLA

Co-Chair

01:30 PM - 01:45 PM - Room 339-342

Anne Galy - PhD - Genethon

88: Development of a FAP-CAR T Cell Protocol to Reduce Skeletal Muscle Fibrosis in a Murine Model of Duchenne Muscular Dystrophy

01:45 PM - 02:00 PM - Room 339-342

Ishwar Navin - MS - Baylor College of Medicine

89: Genetic Depletion of TIGIT Augments CAR-NK Cell Effector Function in the Solid Tumor Microenvironment

02:00 PM - 02:15 PM - Room 339-342

Subhash Tripathi - Ph.D. - Seattle Children’s Research Institute

90: HLA-A2 CAR/IL-2-CISC Engineered Treg Exhibit Robust In Vitro and In Vivo Efficacy

02:15 PM - 02:30 PM - Room 339-342

Jun Choe - Johns Hopkins University School of Medicine

91: Anti-B7-H3 Chimeric Antigen Receptor NK Cells Suppress the Growth of Atypical Teratoid / Rhabdoid Tumor Orthotopic Xenografts

02:30 PM - 02:45 PM - Room 339-342

Chiou-Tsun Tsai - PhD - Baylor College of Medicine

92: An Immune Synapse-Stabilizing Receptor Enhances Sensitivity of CAR- and TCR-Mediated Tumor Targeting

02:45 PM - 03:00 PM - Room 339-342

Brynn Duncan - MD - NIH

93: Transduction with Bicistronic CD20 CAR with NIS Reporter Allows PET/CT Visualization of CAR-T Cell Trafficking In Vivo

03:00 PM - 03:15 PM - Room 339-342

Natalie Holl - Johns Hopkins University School of Medicine

94: Chimeric Cytokine Receptors Induce Antigen-Specific Activation in Natural Killer Cells Against Acute Myeloid Leukemia